Differences in connectivity patterns could reveal which patients are most likely to respond positively to self-guided therapy.

SCAI and HRS have collaborated on new guidelines designed to help clinicians make the safest, smartest treatment decisions possible.

The first coronary DCB to gain FDA approval just received an additional reimbursement that could improve patient access. 

The minimally invasive operation, known as AVATAR, is performed through a small incision in the patient’s neck.

The interventional device, designed to perform both M-TEER and T-TEER, is at the center of two new studies published in EuroIntervention.

Viruses like COVID-19 and the flu could awaken dormant cancer cells that have previously spread to the lungs, triggering growth of metastatic disease.

The American Pharmacists Association is being labeled as a biased special interest group under new rules for the CDC Advisory Committee on Immunization Practices, a move that seems to be politically motivated when APhA did not support changes in COVID vaccines earlier this year. 

Temporary pacemakers are typically used for at least 24 hours before care teams consider implanting a permanent device. New research out of Canada suggests it may make sense in certain scenarios to go straight to the permanent pacemaker.